SCHEMBL7590572

SCHEMBL7590572

CC(Nc1nccc(-n2cnc3cc(NC(=O)OC(C)(C)C)ccc32)n1)C1CCCNC1

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LCK P06239 17/20 0.52
MKNK1 Q9BUB5 2/20 0.42
MKNK2 Q9HBH9 1/20 0.42
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7570274 0.85 LCK (0.56) LCK
SCHEMBL7551010 0.83 LCK (0.75) LCK
SCHEMBL7547222 0.80 LCK (0.76) LCK
SCHEMBL7553602 0.80 LCK (0.76) LCK
SCHEMBL7103389 0.78 LCK (0.79) LCKMKNK1MKNK2
SCHEMBL7589671 0.78 LCK (0.62) LCKMKNK1MKNK2
SCHEMBL7017272 0.77 LCK (0.58) LCK
SCHEMBL7020292 0.76 LCK (0.51) LCKMKNK1MKNK2
SCHEMBL7589591 0.75 LCK (0.58) LCK
SCHEMBL7589687 0.75 LCK (0.68) LCKMKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206260-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-10-30 EP disclosed
EP-1206260-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
US-6329380-B1 PYRIMIDINE BENZIMIDIZAZOLE, PYRIMIDINEIMIDAZOLE OR PYRIDINE IMIDAZOLE COMPOUNDS FOR ANTICANCER AGENTS OR ATHEROSCLEROSIS MERCK & CO., INC. 2001-12-11 US disclosed
WO-2001000207-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed